CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- 4 Planned sale EVP and Chief Legal Officer sold 694 shares at $404.21 ($280,522)
- 4 Planned sale Director sold 266 shares at $386.69 ($102,860)
- 4 Open-market buy CEO & President bought 10,000 shares at an average $389.58 ($3,895,768)
- 4 Open-market buy Director bought 5,000 shares at an average $389.68 ($1,948,416)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes EVP, COO gave up 37,243 shares (to pay taxes)
- 4 Planned sale EVP, Chief Scientific Officer sold 52 shares at $424.69 ($22,084)
- 4 Grant or award EVP, COO acquired 37,622 shares (grant or award)
- 4 Grant or award Director acquired 796 shares (grant or award)
- 4 Grant or award Director acquired 398 shares (grant or award)
- 4 Grant or award Director acquired 796 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 796 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 398 shares (grant or award)
- 4 Grant or award Director acquired 796 shares (grant or award)
- 4 Planned sale Director sold 400 shares at $505.86 ($202,344)
- 4 Derivatives Options or other derivatives
Page 7 of 129 · 2,568 filings